AnalystsJoseph ThomeJoseph Thome's Stock Forecasts
AnalystsJoseph Thome
Sectors:
Analyst Ranking
Bottom 12%
#4077 out of 4572 analysts
Average Return
-16.96%
Win Rate
36%4 out of 11
Risk vs Reward
Poor
Good
Joseph Thome's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Axsome Therapeutics IncAXSM | +105.48% | $36.49 | $74.98 | 2022-06-28 - 2023-06-28 | Buy |
Aerovate Therapeutics IncAVTE | +37.83% | $13.80 | $19.02 | 2021-07-25 - 2022-07-25 | Buy |
Intra Cellular Therapies IncITCI | +17.45% | $59.89 | $70.34 | 2023-12-10 - 2024-05-02 | Buy |
Xenon Pharmaceuticals IncXENE | +0.37% | $38.19 | $38.33 | 2022-12-11 - 2023-12-11 | Buy |
Joseph Thome Analyst Color
Get additional color on Joseph Thome's coverage of popular stocks
Joseph Thome's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Intra Cellular Therapies IncITCI | 2 | Strong Buy | $90.00 | +27.95% | Maintains | 17 days ago |
Ptc Therapeutics IncPTCT | 2 | Hold | $30.00 | -10.77% | Maintains | 2 months ago |
Cerevel Therapeutics Holdings IncCERE | 1 | Hold | $45.00 | +5.66% | Downgrades | 5 months ago |
Xenon Pharmaceuticals IncXENE | 1 | Buy | N/A | N/A | Initiates Coverage On | a year ago |
Acrivon Therapeutics IncACRV | 1 | Buy | N/A | N/A | Initiates Coverage On | a year ago |
Third Harmonic Bio IncTHRD | 1 | Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Axsome Therapeutics IncAXSM | 2 | Buy | $130.00 | N/A | Maintains | 2 years ago |
Epizyme IncEPZM | 1 | Hold | $1.50 | N/A | Downgrades | 2 years ago |
Intellia Therapeutics IncNTLA | 1 | Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Entrada Therapeutics IncTRDA | 1 | Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Aerovate Therapeutics IncAVTE | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Allakos IncALLK | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.